...
首页> 外文期刊>Vaccine >The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis
【24h】

The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis

机译:钩端螺旋体样免疫球蛋白样蛋白LigA的末端部分赋予了对钩端螺旋体病仓鼠模型致死性感染的保护性免疫力

获取原文
获取原文并翻译 | 示例
           

摘要

Subunit vaccines are a potential intervention strategy against leptospirosis, which is a major public health problem in developing countries and a veterinary disease in livestock and companion animals worldwide. Leptospiral immunoglobulin-like (Lig) proteins are a family of surface-exposed determinants that have Ig-like repeat domains found in virulence factors such as intimin and invasin. We expressed fragments of the repeat domain regions of LigA and LigB from Leptospira interrogans serovar Copenhageni. Immunization of Golden Syrian hamsters with Lig fragments in Freund's adjuvant induced robust antibody responses against recombinant protein and native protein, as detected by ELISA and immunoblot, respectively. A single fragment, LigANI, which corresponds to the six carboxy-terminal Ig-like repeat domains of the LigA molecule, conferred immunoprotection against mortality (67-100%, P<0.05) in hamsters which received a lethal inoculum of L. interrogans serovar Copenhageni. However, immunization with this fragment did not confer sterilizing immunity. These findings indicate that the carboxy-terminal portion of LigA is an immunoprotective domain and may serve as a vaccine candidate for human and veterinary leptospirosis.
机译:亚单位疫苗是针对钩端螺旋体病的潜在干预策略,钩端螺旋体病是发展中国家的主要公共卫生问题,也是全世界牲畜和伴侣动物的兽医疾病。钩端螺旋体免疫球蛋白(Lig)蛋白是一类表面暴露的决定簇,具有在毒力因子(如intimin和invasin)中发现的Ig样重复域。我们表达了来自问号钩端螺旋体血清型哥本哈根的LigA和LigB的重复域区域的片段。分别通过ELISA和免疫印迹检测,在弗氏佐剂中用Lig片段免疫金黄叙利亚仓鼠可诱导针对重组蛋白和天然蛋白的强大抗体反应。单个片段LigANI对应于LigA分子的六个羧基末端Ig样重复域,赋予了接受致死性问号杆菌血清的仓鼠免疫死亡保护(67-100%,P <0.05)。哥本哈根。但是,用该片段免疫不会赋予灭菌免疫力。这些发现表明LigA的羧基末端部分是免疫保护结构域,并且可以用作人和兽医钩端螺旋体病的候选疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号